Drug profile · INN
anacaulase-bcdb
NEXOBRID
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
anacaulase-bcdb (NEXOBRID) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN anacaulase-bcdb
Brand NEXOBRID
Route TOPICAL
Formulation GEL
Frequently asked questions
What is anacaulase-bcdb?
anacaulase-bcdb (NEXOBRID) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for anacaulase-bcdb?
NEXOBRID is a marketed brand name for anacaulase-bcdb. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of anacaulase-bcdb?
anacaulase-bcdb has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.